REFERENCES;
1. Walther S, Rettinger E, Maurer HM, et al. Long-term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Pediatric pulmonology.2020.
2. Uhlving HH, Bang CL, Christensen IJ, et al. Lung function after allogeneic hematopoietic stem cell transplantation in children: a longitudinal study in a population-based cohort. Biol Blood Marrow Transplant. 2013;19(9):1348-1354.
3. Shenoy S, Gaziev J, Angelucci E, et al. Late Effects Screening Guidelines after Hematopoietic Cell Transplantation (HCT) for Hemoglobinopathy: Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Biol Blood Marrow Transplant.2018;24(7):1313-1321.
4. Chow EJ, Anderson L, Baker KS, et al. Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children’s Oncology Group Report. Biology of Blood and Marrow Transplantation. 2016;22(5):782-795.
5. Majhail NS, Rizzo JD, Lee SJ, et al. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant.2012;18(3):348-371.
6. Shanthikumar S, Abts M, Liptzin D, et al. Surveillance for Pulmonary Complications of Pediatric Hemopoetic Stem Cell Transplantation-An International Survey of Current Clinical Practices. In: A52. DIFFUSE LUNG DISEASE, ILD, DRUG INDUCED LUNG DISEASE. American Thoracic Society; 2020:A1983-A1983.
7. Yoon JS, Chun YH, Lee JW, Chung NG, Cho B. Value of Screening Spirometry for Early Diagnosis of Bronchiolitis Obliterans Syndrome in Children After Allogeneic Hematopoietic Stem Cell Transplantation.Journal of pediatric hematology/oncology. 2015;37(8):e462-467.
8. Qayed M, Wang T, Hemmer MT, et al. Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.Biol Blood Marrow Transplant. 2018;24(3):521-528.
9. Palmer J, Williams K, Inamoto Y, et al. Pulmonary symptoms measured by the national institutes of health lung score predict overall survival, nonrelapse mortality, and patient-reported outcomes in chronic graft-versus-host disease. Biology of Blood and Marrow Transplantation. 2014;20(3):337-344.